1-8 of 8
Sherwyn Schwartz, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes

Julio Rosenstock, MD, Leslie J. Klaff, MD, PHD, Sherwyn Schwartz, MD, Justin Northrup, MPT, John H. Holcombe, MD, Kenneth Wilhelm, MD, Michael Trautmann, MD
Journal: Diabetes Care
Diabetes Care 2010;33(6):1173–1175
https://doi.org/10.2337/dc09-1203
Published: 23 March 2010
View article titled, Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
Open the PDF for Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes in another window
Journal Articles

Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)

Bernard Zinman, MD, John Gerich, MD, John B. Buse, MD, PHD, Andrew Lewin, MD, Sherwyn Schwartz, MD, Philip Raskin, MD, Paula M. Hale, PHD, Milan Zdravkovic, PHD, Lawrence Blonde, MD, the LEAD-4 Study Investigators
Journal: Diabetes Care
Diabetes Care 2009;32(7):1224–1230
https://doi.org/10.2337/dc08-2124
Published: 16 March 2009
View article titled, Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD)
Open the PDF for Efficacy and Safety of the Human Glucagon-Like Peptide-1 Analog Liraglutide in Combination With Metformin and Thiazolidinedione in Patients With Type 2 Diabetes (LEAD-4 Met+TZD) in another window
Includes: Supplementary data
Journal Articles

Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended-Release Metformin in Patients With Type 2 Diabetes

Sherwyn Schwartz, MD, Vivian Fonseca, MD, MRCP, Bret Berner, PHD, Marilou Cramer, Yu-Kun Chiang, PHD, Andrew Lewin, MD
Journal: Diabetes Care
Diabetes Care 2006;29(4):759–764
https://doi.org/10.2337/diacare.29.04.06.dc05-1967
Published: 01 April 2006
View article titled, Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended-Release Metformin in Patients With Type 2 Diabetes
Open the PDF for Efficacy, Tolerability, and Safety of a Novel Once-Daily Extended-Release Metformin in Patients With Type 2 Diabetes in another window
Journal Articles

Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor: A randomized controlled trial

Satish Garg, MD, Howard Zisser, MD, Sherwyn Schwartz, MD, Timothy Bailey, MD, Roy Kaplan, MD, Samuel Ellis, PHARMD, Lois Jovanovic, MD
Journal: Diabetes Care
Diabetes Care 2006;29(1):44–50
https://doi.org/10.2337/diacare.29.01.06.dc05-1686
Published: 01 January 2006
View article titled, Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor: <subtitle>A randomized controlled trial</subtitle>
Open the PDF for Improvement in Glycemic Excursions With a Transcutaneous, Real-Time Continuous Glucose Sensor: <subtitle>A randomized controlled trial</subtitle> in another window
Journal Articles

Glycemic Characteristics in Continuously Monitored Patients With Type 1 and Type 2 Diabetes: Normative values

Bruce W. Bode, MD, Sherwyn Schwartz, MD, Harrison A. Stubbs, PHD, Jon E. Block, PHD
Journal: Diabetes Care
Diabetes Care 2005;28(10):2361–2366
https://doi.org/10.2337/diacare.28.10.2361
Published: 01 October 2005
View article titled, Glycemic Characteristics in Continuously Monitored Patients With Type 1 and Type 2 Diabetes: <subtitle>Normative values</subtitle>
Open the PDF for Glycemic Characteristics in Continuously Monitored Patients With Type 1 and Type 2 Diabetes: <subtitle>Normative values</subtitle> in another window
Journal Articles

Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults With Type 1 Diabetes

Satish K. Garg, MD, Sherwyn Schwartz, MD, Steven V. Edelman, MD
Journal: Diabetes Care
Diabetes Care 2004;27(3):734–738
https://doi.org/10.2337/diacare.27.3.734
Published: 01 March 2004
View article titled, Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults With Type 1 Diabetes
Open the PDF for Improved Glucose Excursions Using an Implantable Real-Time Continuous Glucose Sensor in Adults With Type 1 Diabetes in another window
Journal Articles

Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes: A dose-timing study

Christian Weyer, MD, Alan Gottlieb, PA, Dennis D. Kim, MD, Karen Lutz, PHD, Sherwyn Schwartz, MD, Maria Gutierrez, MD, Yan Wang, PHD, James A. Ruggles, PHD, Orville G. Kolterman, MD, David G. Maggs, MD
Journal: Diabetes Care
Diabetes Care 2003;26(11):3074–3079
https://doi.org/10.2337/diacare.26.11.3074
Published: 01 November 2003
View article titled, Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes: <subtitle>A dose-timing study</subtitle>
Open the PDF for Pramlintide Reduces Postprandial Glucose Excursions When Added to Regular Insulin or Insulin Lispro in Subjects With Type 1 Diabetes: <subtitle>A dose-timing study</subtitle> in another window
Journal Articles

Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs: Efficacy, safety, and cost analysis

Sherwyn Schwartz, MD, Richard Sievers, DO, Poul Strange, MD, PHD, William H. Lyness, PHD, Priscilla Hollander, MD, For The INS-2061 Study Team
Journal: Diabetes Care
Diabetes Care 2003;26(8):2238–2243
https://doi.org/10.2337/diacare.26.8.2238
Published: 01 August 2003
View article titled, Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs: <subtitle>Efficacy, safety, and cost analysis</subtitle>
Open the PDF for Insulin 70/30 Mix Plus Metformin Versus Triple Oral Therapy in the Treatment of Type 2 Diabetes After Failure of Two Oral Drugs: <subtitle>Efficacy, safety, and cost analysis</subtitle> in another window